ArticleOncology letters2026

Integrated analysis identified MARK4 as a prognostic and immunomodulatory biomarker in oral squamous cell carcinoma.

Xinyue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.